Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

European researchers identify CaSR-targeting antibodies

June 22, 2021

Lunan Pharmaceutical Group describes oleanane cinnamamide derivatives

June 22, 2021

New GTPase KRAS mutant inhibitors presented by Taiho Pharmaceutical

June 22, 2021

Medshine Discovery discloses Chk1 inhibitors for pancreatic cancer

June 22, 2021

Origo Biopharma patents TGFBR1 inhibitors

June 22, 2021

Chinese researchers present CEACAM5- and CD3-targeting antibodies for cancer

June 21, 2021

Bayer and DKFZ synthesize new DGKA inhibitors

June 21, 2021

Canopy Growth divulges new cannabinoid CB1 and CB2 receptor modulators

June 21, 2021

Alnylam Pharmaceuticals divulges ATXN3-targeting ds-siRNAs

June 18, 2021

Chinese investigators describe new JAK inhibitors

June 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.